Broadfin Capital, LLC, 10% Owner at Recro Pharma, Inc. (REPH), sold 162,703 shares at $9.55 ($1.6M) on 2017-11-30, disclosed to the SEC on 2017-11-30.
Open-market sale of $1.6M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.55 | 50,000 | $478K | 30.7% |
| 2 | $9.55 | 100,000 | $955K | 61.4% |
| 3 | $9.63 | 6,322 | $61K | 3.9% |
| 4 | $9.71 | 6,381 | $62K | 4.0% |
| Total | $9.56 avg | 162,703 | $1.6M | 100% |
| Filing → |
| BDSI | SELL | 2019-05-14 | $9.0M | — | Filing → |
| REPH | SELL | 2018-05-24 | $1.1M | — | Filing → |
| REPH | SELL | 2018-03-15 | $2.0M | — | Filing → |